Please login to the form below

Not currently logged in
Email:
Password:

Abbott launches Bluetooth cardiac monitor Confirm RX in the US

The device sits under the patient’s skin and connects to the firm's myMerlin app

heart

Abbott has launched a cardiac monitor in the US that communicates with a patient’s smartphone using Bluetooth wireless technology.

The Confirm RX sits under the patient’s skin and connects to the myMerlin app, which can then be accessed by physicians to identify and diagnose cardiac arrhythmias.

Its approval by the US Food and Drug Administration (FDA) and subsequent launch is a big win for the Chicago healthcare group, as the device is the first and only smartphone compatible ICM in the US.

Avi Fischer, divisional vice president and medical director, cardiac rhythm management business, Abbott, said: “Confirm RX shows what we can do with cutting edge communication technology and the most advanced medical devices that provide new opportunities to improve patient care.

“By offering a device that uses Bluetooth wireless technology from the patient’s smartphone, we can help physicians easily and remotely diagnosed potentially dangerous abnormal heart beats without requiring the patient to use a separate or cumbersome recording device.”

Arrhythmia can develop when a disease or injury disrupts the heart’s electrical signals causing the heart to beat erratically, which can change a patient’s blood flow and cause palpitations, dizziness, shortness of breath of fainting.

Article by
Gemma Jones

7th November 2017

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics